Special Issue "Management of Cardiovascular Disease in Cancer Survivors through Lifestyle Modification"

A special issue of Current Oncology (ISSN 1718-7729).

Deadline for manuscript submissions: 10 June 2022.

Special Issue Editors

Prof. Dr. Melanie Keats
E-Mail Website
Guest Editor
School of Health and Human Performance, Dalhousie University, Halifax, NS B3H 1T8, Canada
Interests: exercise science; exercise intervention; exercise oncology; sport science; physical fitness; cancer survivorship; implementation science
Special Issues and Collections in MDPI journals
Dr. Scott A. Grandy
E-Mail Website
Guest Editor
School of Health and Human Performance, Faculty of Health, Dalhousie University, Halifax, NS B3H 4R2, Canada
Interests: Kinesiology; Exercise and cardiac disease; Cardiac disease prevention; Cardiac cellular function; Cardiac function and aging
Dr. Cynthia Forbes
E-Mail Website
Guest Editor
Faculty of Health Sciences, University of Hull, Hull HU6 7RX, UK
Interests: self-efficacy; exercise; cancer; exercise science; sport science; physical fitness; resistance training; exercise intervention; physical activity assessment; physical education

Special Issue Information

Dear Colleagues,

There is a significant overlap in the risk factors that contribute to the development of cancer and cardiovascular disease (CVD). This, in conjunction with the cardiotoxicity associated with several cancer treatments, significantly increases the risk of cancer survivors developing CVD. This Special Issue of Current Oncology aims to showcase research that uses interventions to reduce the risk of or manage CVD in cancer survivors. We invite researchers to address either one of the following topics or a related topic:

  • lifestyle interventions to prevent/mitigate treatment-related cardiotoxicity;
  • lifestyle interventions to promote cardiovascular health in cancer survivors;
  • lifestyle interventions used to manage CVD in cancer survivors; or
  • interventions aimed at reducing risk factors common to cancer and CVD.

Prof. Dr. Melanie Keats
Dr. Scott A. Grandy
Dr. Cynthia Forbes
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lifestyle interventions
  • cancer survivors
  • physical activity
  • cardiovascular disease

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

Review
Exercise to Reduce Anthracycline-Mediated Cardiovascular Complications in Breast Cancer Survivors
Curr. Oncol. 2021, 28(5), 4139-4156; https://doi.org/10.3390/curroncol28050351 - 13 Oct 2021
Viewed by 229
Abstract
While developments in cancer therapeutics have greatly reduced morbidity and mortality in females with breast cancer, it comes at a cost of an increased risk of cardiovascular complications. In particular, anthracyclines, like doxorubicin, which are a mainstay of current chemotherapy regimens, are associated [...] Read more.
While developments in cancer therapeutics have greatly reduced morbidity and mortality in females with breast cancer, it comes at a cost of an increased risk of cardiovascular complications. In particular, anthracyclines, like doxorubicin, which are a mainstay of current chemotherapy regimens, are associated with dose-dependent cardiotoxicity. Exercise has been widely accepted as an effective intervention in reducing cardiovascular risk in a variety of different clinical conditions. However, the benefits of exercise in anthracycline-mediated cardiotoxicity are not clearly understood. First, this review discusses the pre-clinical studies which have elucidated the cardioprotective mechanisms of aerobic and resistance exercise in improving cardiovascular function in the setting of anthracycline treatment. Next, it aims to summarize the results of aerobic and resistance exercise clinical trials conducted in females with breast cancer who received anthracycline-based chemotherapy. The review further discusses the current exercise guidelines for women undergoing chemotherapy and contraindications for exercise. Finally, the review addresses gaps in research, specifically the need for further clinical trials to establish a recommended exercise prescription within this patient population. Full article
Back to TopTop